Citius (CTXR) Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal Trial
PHASE III PROGRESS
October 7th, 2019, Citius Completes 40% - Triggers Data Being Analyzed (is it working?).December 19th, 2019 - Data Analysis Back, Results Positive.February...
Okay, so What’s Next for Citius Pharma (CTXR) $1.16?
Dawson James Broker/Dealer Updates. Price Target Remains at $7.00.
"OK, So what’s Next? Topline data from the superior efficacy interim analysis should represent the next...
Citius Pharma (CTXR) $1.20. Price Target Upped to $4.00 at HC Wainright.
STREET INSIDER
H.C. Wainwright analyst Vernon Bernardino raised the price target on Citius Pharmaceuticals (NASDAQ: CTXR) to $4.00 (from $1.65) while maintaining a Buy rating.
The analyst commented,...
VIDEO: Dyadic (DYAI) CEO Explains What his Industry is Doing to Defeat Coronavirus (FoxNews).
Jan. 27, 2020 - 5:24 - Dyadic International CEO Mark Emalfarb discusses what’s being done to stop the spread of coronavirus and to...
Stand Down V: MAGA. Each Crossing $1 Trillion, Microsoft, Amazon, Google, and AAPL.
Is this today's version of the Nifty 50?
Microsoft $1.3 Trillion
Apple $1.3 Trillion
Google $1 Trillion
Amazon $1 Trillion
Biotech Stock Review: Biotech 5 Pack. 5 Biotech Stocks...
CoronaVirus Watch List Stocks in the News (Bloomberg, Benzinga).
INITIAL WATCHLIST: CoronaVirus Watch List | Superbug Stock Review
Aethlon Medical, Inc. (NASDAQ: AEMD) $2.40 Alpha Pro Tech, Ltd. (NYSE: APT) $6.00AstraZeneca plc (NYSE: AZN) $49BioCryst Pharmaceuticals, Inc.'s (NASDAQ: BCRX) $2.80 Cerus Corporation (NASDAQ: CERS)...
Biotech 5 Pack. 5 Biotech Stocks We Expect to Double in 2020.
Our First Newsletter of 2020, We Come out Swinging!
Yes, you read it right. Five of our favorite Biotech stocks that have the potential to...
New Report: Citius Pharma (CTXR) Now Our #1 Ranked Idea for 2020.
Citius Pharmaceuticals (CTXR) is hands down one of the most exciting long-term opportunities we have come across since we first launched the Biotech Stock...
Citius Pharma (CTXR) Corporate Presentation (Jan 2020).
In the above graphic, the catheter can get infected by bacteria and most typically see evidence of the infection (see gross graphic below) at...
Oramed (ORMP) $5.24, Focused on Pill Form Insulin. Is China First?
New technology could revolutionize market of 500 million diabetes patients (i24 News).
LIVE CHART
Oramed Pharmaceuticals (ORMP) developed insulin capsule that can be consumed orally
A new...
Latest article
REPORT OpenWorld: The Contrarian’sCase for OPNW
Adding to Watch List. Why VerifyMe's (VRME) $0.90 Reverse Merger Deserves a Second Look. Or First Look for Some.
LIVE QUOTE
RECENT NEWS
VerifyMe Reports Fourth Quarter...
$269 Million in Cash and a $178 Million Market Cap. What are the Odds?...
Wife: "Honey, I'm going to the mall, do we have money in the checking?" CEO "Yes, but don't go crazy, we're down to $269...
Former CIA Deputy Director and Chief Technology Officer Joins Sekur Private Data (SWISF).
Strategic Advisory Board Member John T. Lewis, Role Expanded to Chief Technology Officer At Sekur Private Data.
The press release link below list nearly all of...
